Mckesson (MCK) Cash from Investing Activities (2009 - 2026)
Mckesson (MCK) reported Cash from Investing Activities of $425.0 million for Q1 2026, up 289.73% year-over-year from $109.0 million in Q1 2025, and up 257.99% quarter-over-quarter from -$269.0 million in Q4 2025.
Mckesson (MCK) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Cash from Investing Activities data on file, last reported at $425.0 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $425.0 million, up 289.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.4 billion (down 368.21% YoY), and the FY2026 annual result was -$3.4 billion, down 368.21% from the prior year.
- Cash from Investing Activities improved to $425.0 million in Q1 2026 per MCK's latest filing, from -$269.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $425.0 million in Q1 2026 and troughed at -$3.6 billion in Q2 2025.
- A 5-year average of -$329.2 million and a median of -$166.0 million in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities sank 3996.55% in 2025, then jumped 289.73% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at -$414.0 million in 2022, then jumped by 56.52% to -$180.0 million in 2023, then climbed by 24.44% to -$136.0 million in 2024, then tumbled by 97.79% to -$269.0 million in 2025, then soared by 257.99% to $425.0 million in 2026.
- Business Quant data shows MCK's Cash from Investing Activities at $425.0 million in Q1 2026, -$269.0 million in Q4 2025, and -$24.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 425.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -4.87 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -181.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -63.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 53.93 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -754,000.00 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -3.21 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -708,963.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425.00 Mn |
| Mar 31, 2026 | 425.00 Mn |
| Dec 31, 2025 | -269.00 Mn |
| Dec 31, 2025 | -269.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Jun 30, 2025 | -3.56 Bn |
| Jun 30, 2025 | -3.56 Bn |
| Mar 31, 2025 | -224.00 Mn |
| Mar 31, 2025 | -224.00 Mn |
| Dec 31, 2024 | -136.00 Mn |
| Dec 31, 2024 | -136.00 Mn |
| Sep 30, 2024 | -286.00 Mn |
| Sep 30, 2024 | -286.00 Mn |
| Jun 30, 2024 | -87.00 Mn |
| Jun 30, 2024 | -87.00 Mn |
| Mar 31, 2024 | -577.00 Mn |
| Mar 31, 2024 | -577.00 Mn |
| Dec 31, 2023 | -180.00 Mn |
| Dec 31, 2023 | -180.00 Mn |